NCT06550518View on ClinicalTrials.gov

Real-life Second-line Epirubicin-Paclitaxel Regimen as Treatment of Relapsed Small-Cell Lung Cancer : EpiTax Study.

CompletedOBSERVATIONAL

Enrollment

29

Participants

Timeline

Start Date

May 4, 2021

Primary Completion Date

December 12, 2021

Study Completion Date

December 12, 2021

Conditions

Advanced Small Cell Lung Carcinoma

Trial Locations (3)

29000

CHIC, Quimper

29609

CHRU de Brest, Brest

29800

Hôpital de Landerneau, Landerneau

All Listed Sponsors

lead

University Hospital, Brest

OTHER